Browse related articlesQatar shows highest diabetes rate
Qatar: Monday, November 03 - 2008 at 10:03
Qatar is leading the GCC region with the highest rate of Type I diabetes according to the Qatar 2006 World Health Survey. Dr Gail Fraser Chanpong, Director, Public Health Department National Health Authority (NHA) said the Qatar health survey shows that 12% of adults were diabetic and 10% were classified as pre-diabetic, only 30% had a healthy weight and 28% of children below five years were obese.
See Also
Also consider reading:
- » Health services 'failing' underprivileged
- » New medical residency medical centre to open in Dubai
- » UAE onboard UN body on tropical disease
- » New medical product development centre opens in Jordan
- » Foreign trips for medical travel often rejected
- » WHO to assist Qatar
- » Breast Cancer treatment now available in the UAE
- » GCC spend to quadruple
- » UAE approves HIV drug sales
- » Overall satisfaction with Dubai healthcare services, survey finds
Facebook
LinkedIn
Digg
StaffMonday, November 03 - 2008 at 10:03 UAE local time (GMT+4)
Replication or redistribution in whole or in part is expressly prohibited without the prior written consent of AME Info FZ LLC / Emap Limited.
Disclaimer:
The information comprised in this section is not, nor is it held out to be, a solicitation of any person to take any form of investment decision. The content of the AME Info Web site does not constitute advice or a recommendation by AME Info FZ LLC / Emap Limited and should not be relied upon in making (or refraining from making) any decision relating to investments or any other matter. You should consult your own independent financial adviser and obtain professional advice before exercising any investment decisions or choices based on information featured in this AME Info Web site.
AME Info FZ LLC / Emap Limited can not be held liable or responsible in any way for any opinions, suggestions, recommendations or comments made by any of the contributors to the various columns on the AME Info Web site nor do opinions of contributors necessarily reflect those of AME Info FZ LLC / Emap Limited.
In no event shall AME Info FZ LLC / Emap Limited be liable for any damages whatsoever, including, without limitation, direct, special, indirect, consequential, or incidental damages, or damages for lost profits, loss of revenue, or loss of use, arising out of or related to the AME Info Web site or the information contained in it, whether such damages arise in contract, negligence, tort, under statute, in equity, at law or otherwise.
The information comprised in this section is not, nor is it held out to be, a solicitation of any person to take any form of investment decision. The content of the AME Info Web site does not constitute advice or a recommendation by AME Info FZ LLC / Emap Limited and should not be relied upon in making (or refraining from making) any decision relating to investments or any other matter. You should consult your own independent financial adviser and obtain professional advice before exercising any investment decisions or choices based on information featured in this AME Info Web site.
AME Info FZ LLC / Emap Limited can not be held liable or responsible in any way for any opinions, suggestions, recommendations or comments made by any of the contributors to the various columns on the AME Info Web site nor do opinions of contributors necessarily reflect those of AME Info FZ LLC / Emap Limited.
In no event shall AME Info FZ LLC / Emap Limited be liable for any damages whatsoever, including, without limitation, direct, special, indirect, consequential, or incidental damages, or damages for lost profits, loss of revenue, or loss of use, arising out of or related to the AME Info Web site or the information contained in it, whether such damages arise in contract, negligence, tort, under statute, in equity, at law or otherwise.
Web Feeds